Aurinia Pharmaceuticals IncNASDAQ:AUPH
- LAST PRICE5.6800
- TODAY'S CHANGE (%)0.0800 (1.4286%)
- Bid / Lots5.5700/ 2
- Ask / Lots5.7300/ 5
- Open / Previous Close5.6600 / 5.6000
- Day Range
- 52 Week Range
- Volume1,012,754
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUPH |
|---|---|---|
| 09:32 ET | 17196 | 5.61 |
| 09:34 ET | 380 | 5.635 |
| 09:36 ET | 20829 | 5.64 |
| 09:38 ET | 16931 | 5.65 |
| 09:39 ET | 3244 | 5.63 |
| 09:41 ET | 900 | 5.62 |
| 09:43 ET | 2805 | 5.615 |
| 09:45 ET | 13245 | 5.635 |
| 09:48 ET | 2886 | 5.655 |
| 09:50 ET | 2321 | 5.655 |
| 09:52 ET | 16491 | 5.655 |
| 09:54 ET | 10037 | 5.665 |
| 09:56 ET | 2914 | 5.68 |
| 09:57 ET | 5601 | 5.66 |
| 09:59 ET | 26781 | 5.655 |
| 10:01 ET | 7671 | 5.685 |
| 10:03 ET | 8850 | 5.665 |
| 10:06 ET | 2581 | 5.665 |
| 10:08 ET | 3300 | 5.635 |
| 10:10 ET | 10498 | 5.625 |
| 10:12 ET | 4649 | 5.635 |
| 10:14 ET | 13921 | 5.625 |
| 10:15 ET | 7826 | 5.59 |
| 10:17 ET | 1238 | 5.62 |
| 10:19 ET | 3515 | 5.64 |
| 10:21 ET | 850 | 5.64 |
| 10:24 ET | 497 | 5.64 |
| 10:26 ET | 750 | 5.645 |
| 10:28 ET | 5581 | 5.65 |
| 10:30 ET | 6175 | 5.645 |
| 10:32 ET | 11023 | 5.635 |
| 10:33 ET | 2573 | 5.65 |
| 10:35 ET | 200 | 5.65 |
| 10:37 ET | 11818 | 5.645 |
| 10:39 ET | 1248 | 5.65 |
| 10:42 ET | 9973 | 5.65 |
| 10:44 ET | 1500 | 5.645 |
| 10:46 ET | 600 | 5.65 |
| 10:48 ET | 400 | 5.645 |
| 10:50 ET | 2000 | 5.645 |
| 10:51 ET | 12553 | 5.635 |
| 10:53 ET | 3541 | 5.65 |
| 10:55 ET | 1550 | 5.65 |
| 10:57 ET | 1709 | 5.66 |
| 11:00 ET | 1067 | 5.665 |
| 11:02 ET | 350 | 5.665 |
| 11:04 ET | 1789 | 5.655 |
| 11:06 ET | 100 | 5.655 |
| 11:08 ET | 2796 | 5.635 |
| 11:09 ET | 865 | 5.65 |
| 11:11 ET | 700 | 5.645 |
| 11:13 ET | 250 | 5.641 |
| 11:15 ET | 2800 | 5.635 |
| 11:18 ET | 100 | 5.64 |
| 11:22 ET | 1200 | 5.63 |
| 11:24 ET | 4561 | 5.635 |
| 11:26 ET | 1490 | 5.645 |
| 11:27 ET | 1118 | 5.65 |
| 11:29 ET | 400 | 5.645 |
| 11:31 ET | 3485 | 5.645 |
| 11:33 ET | 300 | 5.65 |
| 11:36 ET | 655 | 5.645 |
| 11:38 ET | 2091 | 5.655 |
| 11:40 ET | 484 | 5.655 |
| 11:42 ET | 564 | 5.655 |
| 11:44 ET | 671 | 5.655 |
| 11:45 ET | 1089 | 5.655 |
| 11:47 ET | 200 | 5.655 |
| 11:49 ET | 736 | 5.65 |
| 11:51 ET | 503 | 5.655 |
| 11:54 ET | 216 | 5.655 |
| 11:56 ET | 2130 | 5.66 |
| 11:58 ET | 100 | 5.655 |
| 12:00 ET | 7331 | 5.665 |
| 12:02 ET | 100 | 5.67 |
| 12:03 ET | 2708 | 5.685 |
| 12:05 ET | 200 | 5.69 |
| 12:07 ET | 500 | 5.69 |
| 12:09 ET | 872 | 5.69 |
| 12:12 ET | 1113 | 5.695 |
| 12:14 ET | 4065 | 5.675 |
| 12:16 ET | 5746 | 5.676 |
| 12:18 ET | 3749 | 5.675 |
| 12:21 ET | 500 | 5.675 |
| 12:23 ET | 2519 | 5.67 |
| 12:25 ET | 1000 | 5.665 |
| 12:27 ET | 347 | 5.665 |
| 12:30 ET | 200 | 5.665 |
| 12:32 ET | 200 | 5.67 |
| 12:34 ET | 669 | 5.665 |
| 12:36 ET | 5939 | 5.665 |
| 12:38 ET | 2083 | 5.665 |
| 12:39 ET | 400 | 5.67 |
| 12:41 ET | 400 | 5.67 |
| 12:43 ET | 1500 | 5.68 |
| 12:45 ET | 2159 | 5.675 |
| 12:50 ET | 10777 | 5.675 |
| 12:52 ET | 5039 | 5.675 |
| 12:56 ET | 200 | 5.67 |
| 12:57 ET | 752 | 5.67 |
| 12:59 ET | 1152 | 5.665 |
| 01:01 ET | 226 | 5.665 |
| 01:03 ET | 200 | 5.665 |
| 01:06 ET | 900 | 5.68 |
| 01:08 ET | 400 | 5.675 |
| 01:10 ET | 2800 | 5.66 |
| 01:12 ET | 2200 | 5.665 |
| 01:14 ET | 2772 | 5.655 |
| 01:15 ET | 100 | 5.655 |
| 01:17 ET | 453 | 5.65 |
| 01:19 ET | 100 | 5.655 |
| 01:21 ET | 809 | 5.66 |
| 01:24 ET | 1320 | 5.655 |
| 01:26 ET | 1050 | 5.66 |
| 01:28 ET | 800 | 5.67 |
| 01:30 ET | 5659 | 5.665 |
| 01:32 ET | 1479 | 5.655 |
| 01:33 ET | 20711 | 5.635 |
| 01:35 ET | 17438 | 5.635 |
| 01:37 ET | 1300 | 5.64 |
| 01:39 ET | 533 | 5.645 |
| 01:42 ET | 17650 | 5.65 |
| 01:44 ET | 5672 | 5.655 |
| 01:46 ET | 1386 | 5.66 |
| 01:48 ET | 6984 | 5.675 |
| 01:50 ET | 874 | 5.675 |
| 01:51 ET | 2355 | 5.66 |
| 01:53 ET | 100 | 5.67 |
| 01:55 ET | 2584 | 5.685 |
| 01:57 ET | 100 | 5.69 |
| 02:00 ET | 300 | 5.68 |
| 02:02 ET | 200 | 5.69 |
| 02:04 ET | 19270 | 5.69 |
| 02:06 ET | 3720 | 5.685 |
| 02:08 ET | 700 | 5.685 |
| 02:09 ET | 806 | 5.695 |
| 02:11 ET | 100 | 5.69 |
| 02:13 ET | 300 | 5.695 |
| 02:15 ET | 200 | 5.69 |
| 02:18 ET | 900 | 5.7 |
| 02:20 ET | 4618 | 5.69 |
| 02:22 ET | 1200 | 5.695 |
| 02:24 ET | 2200 | 5.69 |
| 02:26 ET | 200 | 5.7 |
| 02:27 ET | 700 | 5.695 |
| 02:29 ET | 400 | 5.69 |
| 02:31 ET | 700 | 5.69 |
| 02:33 ET | 2544 | 5.69 |
| 02:36 ET | 1200 | 5.695 |
| 02:38 ET | 4300 | 5.695 |
| 02:40 ET | 1659 | 5.7 |
| 02:42 ET | 700 | 5.69 |
| 02:44 ET | 300 | 5.695 |
| 02:45 ET | 850 | 5.69 |
| 02:47 ET | 700 | 5.69 |
| 02:49 ET | 600 | 5.7 |
| 02:51 ET | 16922 | 5.695 |
| 02:54 ET | 5279 | 5.69 |
| 02:56 ET | 533 | 5.685 |
| 02:58 ET | 2013 | 5.69 |
| 03:00 ET | 1204 | 5.685 |
| 03:02 ET | 518 | 5.685 |
| 03:03 ET | 1650 | 5.675 |
| 03:05 ET | 300 | 5.675 |
| 03:07 ET | 2573 | 5.665 |
| 03:09 ET | 900 | 5.665 |
| 03:12 ET | 45880 | 5.655 |
| 03:14 ET | 5448 | 5.665 |
| 03:16 ET | 7869 | 5.675 |
| 03:18 ET | 1421 | 5.675 |
| 03:20 ET | 4128 | 5.675 |
| 03:21 ET | 3692 | 5.685 |
| 03:23 ET | 396 | 5.69 |
| 03:25 ET | 2585 | 5.7 |
| 03:27 ET | 862 | 5.695 |
| 03:30 ET | 2427 | 5.695 |
| 03:32 ET | 9067 | 5.685 |
| 03:34 ET | 8130 | 5.675 |
| 03:36 ET | 1530 | 5.68 |
| 03:38 ET | 2400 | 5.68 |
| 03:39 ET | 1150 | 5.675 |
| 03:41 ET | 4310 | 5.685 |
| 03:43 ET | 5129 | 5.675 |
| 03:45 ET | 5648 | 5.675 |
| 03:48 ET | 1020 | 5.6791 |
| 03:50 ET | 3008 | 5.675 |
| 03:52 ET | 7286 | 5.67 |
| 03:54 ET | 3289 | 5.675 |
| 03:56 ET | 10376 | 5.675 |
| 03:57 ET | 35555 | 5.7 |
| 03:59 ET | 131908 | 5.68 |
Jul 19, 2024
Press Release: Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024, from 6:00AM ET on Friday Jul 19, 2024 by Dow Jones
6:00AM ET on Friday Jul 19, 2024 by Dow JonesAurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024, from 6:00AM ET on Friday Jul 19, 2024 by Dow Jones
6:00AM ET on Friday Jul 19, 2024 by Dow Jones
Jul 2, 2024
Aurinia to Participate in Upcoming Investor Healthcare Conferences, from 6:00AM ET on Tuesday Jul 02, 2024 by Dow Jones
6:00AM ET on Tuesday Jul 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Aurinia Pharmaceuticals Inc | 800.9M | -13.0x | --- |
Adaptive Biotechnologies Corp | 638.1M | -3.0x | --- |
Arcturus Therapeutics Holdings Inc | 618.9M | -6.0x | --- |
Travere Therapeutics Inc | 743.8M | -1.9x | --- |
Avid Bioservices Inc | 656.2M | -4.6x | --- |
Anika Therapeutics Inc | 419.8M | -5.3x | --- |
Company Information
Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct pre-clinical, clinical, and regulatory activities to support the voclosporin development program. LUPKYNIS is a calcineurin inhibitor (CNI) immunosuppressant, that improves near and long-term outcomes in LN when used in combination with mycophenolate mofetil (MMF) and steroids. LUPKYNIS reduces cytokine activation and blocks interleukin IL-2 expression and T-cell mediated immune responses. Voclosporin, the active ingredient in LUPKYNIS, is made by a modification of a single amino acid of the cyclosporine molecule. Its product pipeline includes AUR200 and AUR300.
Contact Information
- Headquarters
- #140, 14315 - 118 AVENUEVICTORIA, BC, Canada T5L 4S6
- Phone
- 250-744-2487
- Fax
- 604-369-4115
Executives
- Independent Chairman of the Board
- Daniel Billen
- President, Chief Executive Officer, Director
- Peter Greenleaf
- Chief Financial Officer
- Joe Miller
- Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
- Stephen Robertson
- Executive Vice President, Operations and Strategy
- Matthew Donley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $800.9M |
|---|---|
Revenue (TTM) | $191.4M |
Shares Outstanding | 143.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.45 |
EPS | $-0.44 |
Book Value | $2.63 |
P/E Ratio | -13.0x |
Price/Sales (TTM) | 4.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -39.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
